BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 17384178)

  • 1. Systemic sclerosis-rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity.
    Szücs G; Szekanecz Z; Zilahi E; Kapitány A; Baráth S; Szamosi S; Végvári A; Szabó Z; Szántó S; Czirják L; György Kiss C
    Rheumatology (Oxford); 2007 Jun; 46(6):989-93. PubMed ID: 17384178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
    Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
    Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the HLA-DRB1 gene and clinical features of systemic sclerosis in Korea.
    Joung CI; Jun JB; Chung WT; Song GG; Choe JY; Chang HK; Yoo DH
    Scand J Rheumatol; 2006; 35(1):39-43. PubMed ID: 16467040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.
    Kapitány A; Szabó Z; Lakos G; Aleksza M; Végvári A; Soós L; Karányi Z; Sipka S; Szegedi G; Szekanecz Z
    Isr Med Assoc J; 2008 Jan; 10(1):32-6. PubMed ID: 18300568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of rheumatoid arthritis with HLA-DR1 and HLA-DR4 in Hungary.
    Kapitány A; Zilahi E; Szántó S; Szücs G; Szabó Z; Végvári A; Rass P; Sipka S; Szegedi G; Szekanecz Z
    Ann N Y Acad Sci; 2005 Jun; 1051():263-70. PubMed ID: 16126967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis.
    Liakouli V; Manetti M; Pacini A; Tolusso B; Fatini C; Toscano A; Cipriani P; Guiducci S; Bazzichi L; Codullo V; Ruocco L; Dell'orso L; Carubbi F; Marrelli A; Abbate R; Bombardieri S; Ferraccioli G; Montecucco C; Valentini G; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R
    Ann Rheum Dis; 2009 Apr; 68(4):584-90. PubMed ID: 18445624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and immunological differences between Japanese patients with diffuse scleroderma and limited scleroderma.
    Satoh M; Akizuki M; Kuwana M; Mimori T; Yamagata H; Yoshida S; Homma M; Yamamoto T; Sasazuki T
    J Rheumatol; 1994 Jan; 21(1):111-4. PubMed ID: 8151564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DR1, DR4, and DRB1 disease related subtypes in rheumatoid arthritis. Association with susceptibility but not severity in a city wide community based study.
    Suarez-Almazor ME; Tao S; Moustarah F; Russell AS; Maksymowych W
    J Rheumatol; 1995 Nov; 22(11):2027-33. PubMed ID: 8596139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmunity to native type II collagen--a distinct genetic subset of rheumatoid arthritis.
    Klimiuk PS; Clague RB; Grennan DM; Dyer PA; Smeaton I; Harris R
    J Rheumatol; 1985 Oct; 12(5):865-70. PubMed ID: 3878877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between beta2 adrenergic receptor polymorphisms and rheumatoid arthritis in conjunction with human leukocyte antigen (HLA)-DRB1 shared epitope.
    Malysheva O; Pierer M; Wagner U; Wahle M; Wagner U; Baerwald CG
    Ann Rheum Dis; 2008 Dec; 67(12):1759-64. PubMed ID: 18267980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seronegative rheumatoid arthritis and HLA-DR4.
    al-Jarallah KF; Buchanan WW; Sastry A; Singal DP
    J Rheumatol; 1994 Feb; 21(2):190-3. PubMed ID: 8182622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis.
    Michou L; Teixeira VH; Pierlot C; Lasbleiz S; Bardin T; Dieudé P; Prum B; Cornélis F; Petit-Teixeira E
    Ann Rheum Dis; 2008 Apr; 67(4):466-70. PubMed ID: 17660221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
    Mondini M; Vidali M; De Andrea M; Azzimonti B; Airò P; D'Ambrosio R; Riboldi P; Meroni PL; Albano E; Shoenfeld Y; Gariglio M; Landolfo S
    Arthritis Rheum; 2006 Dec; 54(12):3939-44. PubMed ID: 17133607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis.
    Poór G; Nagy ZB; Schmidt Z; Brózik M; Merétey K; Gergely P
    Ann N Y Acad Sci; 2007 Sep; 1110():23-32. PubMed ID: 17911417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.
    Wedderburn LR; McHugh NJ; Chinoy H; Cooper RG; Salway F; Ollier WE; McCann LJ; Varsani H; Dunphy J; North J; Davidson JE;
    Rheumatology (Oxford); 2007 Dec; 46(12):1786-91. PubMed ID: 18003662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-agalactosyl IgG antibodies in sera from patients with systemic sclerosis.
    Nishijima C; Sato S; Takehara K
    J Rheumatol; 2001 Aug; 28(8):1847-51. PubMed ID: 11508588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of HLA-DR polymorphism in polymyalgia rheumatica. Swiss Group for Research on HLA in Polymyalgia Rheumatica.
    Guerne PA; Salvi M; Seitz M; Bruhlmann P; Rivier G; Frey D; Mermillod B; Vischer TL; Tiercy JM
    J Rheumatol; 1997 Apr; 24(4):671-6. PubMed ID: 9101500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome.
    Zimmermann C; Steiner G; Skriner K; Hassfeld W; Petera P; Smolen JS
    Arthritis Rheum; 1998 Nov; 41(11):1938-45. PubMed ID: 9811047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.